C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 403/06 (2006.01) A61K 31/496 (2006.01) A61P 15/06 (2006.01)
Patent
CA 2571529
Compounds of formula (IA) wherein R1 is 2-indanyl, R2 is 1-methylpropyl, R3 is 1-methyl-indazol-5-yl, R4 represents methyl and R5 represents hydrogen or methyl, and pharmaceutically acceptable derivatives thereof are described, as are processes for their preparation, pharmaceutical compositions containing them and their use in medicine, particularly their use as oxytocin antagonists.
Cette invention concerne des composés représentés par la formule (IA), dans laquelle R1 représente 2-indanyle, R2 représente 1-méthylpropyle, R3 représente 1-méthyl-indazol-5-yle, R4 représente méthyle et R5 représente hydrogène ou méthyle, et des dérivés de ceux-ci acceptables sur le plan pharmaceutique, ainsi que des procédés pour leur préparation, des compositions pharmaceutiques les contenants et leur utilisation en médecine, notamment comme antagonistes des oxytocines.
Borthwick Alan David
Sollis Steven Leslie
Glaxo Group Limited
Gowling Lafleur Henderson Llp
LandOfFree
Substituted diketopiperazines as oxytocin antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted diketopiperazines as oxytocin antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted diketopiperazines as oxytocin antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1982609